Company / Income Tax
NewAmsterdam Pharma Co N.V. Income Tax History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$1.0K
FY2024
5-year range
-$1.0K / $27.0K
FY2023-FY2024
Trend
-103.7%
vs FY2023
Sector context
#166 of 200
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s income tax of -$1,000 is lower than 83% of companies in the Health Care sector (FY2024).
Based on SEC 10-K filings.
-$1,000 in FY2024.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 200This company -$1.0K Sector average $126.4M
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, income tax decreased 103.7% year-over-year.
- Ranks #166 out of 200 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$1.0K | -103.7% |
| FY2023 | $27.0K | - |
| FY2022 | - | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026